SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-08-006620
Filing Date
2008-06-05 17:13:06
Period of Report
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y60079ke8vk.htm 8-K 19119
  Complete submission text file 0000950123-08-006620.txt   21071
Mailing Address SUITE 104 790 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address SUITE 104 790 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-252-6920
Sirtris Pharmaceuticals, Inc. (Filer) CIK: 0001388775 (see all company filings)

IRS No.: 201410189 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33465 | Film No.: 08883762
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1